NASDAQ · CTXR

Citius Pharmaceuticals, Inc.

Closing price · Nov 13, 2026 $0.5351

Latest quarter · ended Jun 30, 2026

Sales slipped and cash got weaker

descriptionFiled Aug 14, 2026
Revenue growth
—Sales for the quarter: $1.49M
Gross marginSteady
67.1%
Quarter ended Dec 31, 2025: 80.0% gross marginQuarter ended Mar 31, 2026: 80.3% gross marginQuarter ended Jun 30, 2026: 67.1% gross margin
Dec '25Jun '26
Cash from operationsWorse
−$8.68M
Quarter ended Sep 30, 2024: −$5.91M cash from operationsQuarter ended Dec 31, 2024: −$4.73M cash from operationsQuarter ended Mar 31, 2025: −$4.54M cash from operationsQuarter ended Jun 30, 2025: −$5.41M cash from operationsQuarter ended Sep 30, 2025: −$11.9M cash from operationsQuarter ended Dec 31, 2025: −$13M cash from operationsQuarter ended Mar 31, 2026: −$1.3M cash from operationsQuarter ended Jun 30, 2026: −$8.68M cash from operations
Sep '24Jun '26
vs. −$5.41M a year ago
Share countDiluting
+61.4%
Quarter ended Sep 30, 2024: 7.73M sharesQuarter ended Dec 31, 2024: 8.59M sharesQuarter ended Mar 31, 2025: 10.29M sharesQuarter ended Jun 30, 2025: 17.01M sharesQuarter ended Sep 30, 2025: 20.76M sharesQuarter ended Dec 31, 2025: 22.38M sharesQuarter ended Mar 31, 2026: 27.45M sharesQuarter ended Jun 30, 2026: 27.45M shares
Sep '24Jun '26
27.45M shares vs. 17.01M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 0
  • info
    No real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

44 funds report owning CTXR, up from 37

Holdings as of Jun 30, 2026
New14
Added7
Held16
Trimmed7
Sold out7

Insider trades · last 12 months

Real buys and sales

No insider filings loaded for the last 12 months.

Top holders

Biggest funds in CTXR

As of Jun 30, 2026
FundOwnsValueChange
Geode Capital Management, LLC0.8%$130K−12%
Vanguard Capital Management LLC0.7%$119K+18%
Miller Financial Services LLC0.5%$78.6K+829%
Citadel Advisors LLC0.5%$75.5KNew
Jane Street Group, LLC0.4%$74.3K+445%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist